Head of Finance
Karen Gilmore is Head of Finance for Optera Therapeutics Corp. She has over 25 years’ experience serving both public and private companies with a heavy concentration in biotech and medical device. Most recently, Karen played a key role as CFO for Tear Film Innovations helping them raise over $17M in funding and then with their recent acquisition by Alcon. Karen has been providing CFO/Controller services for many companies, including City Hill Ventures and their portfolio companies (Ignyta, Medenovo and Eclipse Therapeutics), as well as Erasca, SPIWay, GPB Scientific and HealthFusion to name a few. Karen began her career with Coopers & Lybrand (currently PriceWaterhouseCoopers). She has a Bachelor of Science degree from California State Polytechnic University, Pomona and is a Certified Public Accountant.